159 related articles for article (PubMed ID: 37449857)
1. High-deductible Health Plans and Nonfatal Opioid Overdose.
Eddelbuettel JCP; Barry CL; Kennedy-Hendricks A; Busch AB; Hollander MAG; Huskamp HA; Meiselbach MK; Schilling C; Stuart EA; Eisenberg MD
Med Care; 2023 Sep; 61(9):601-604. PubMed ID: 37449857
[TBL] [Abstract][Full Text] [Related]
2. Impact of High Deductible Health Plans on Continuous Buprenorphine Treatment for Opioid Use Disorder.
Kennedy-Hendricks A; Schilling CJ; Busch AB; Stuart EA; Huskamp HA; Meiselbach MK; Barry CL; Eisenberg MD
J Gen Intern Med; 2022 Mar; 37(4):769-776. PubMed ID: 34405345
[TBL] [Abstract][Full Text] [Related]
3. Public Health Interventions and Overdose-Related Outcomes Among Persons With Opioid Use Disorder.
Nataraj N; Rikard SM; Zhang K; Jiang X; Guy GP; Rice K; Mattson CL; Gladden RM; Mustaquim DM; Illg ZN; Seth P; Noonan RK; Losby JL
JAMA Netw Open; 2024 Apr; 7(4):e244617. PubMed ID: 38568691
[TBL] [Abstract][Full Text] [Related]
4. State- and County-Level Geographic Variation in Opioid Use Disorder, Medication Treatment, and Opioid-Related Overdose Among Medicaid Enrollees.
Lindner SR; Hart K; Manibusan B; McCarty D; McConnell KJ
JAMA Health Forum; 2023 Jun; 4(6):e231574. PubMed ID: 37351873
[TBL] [Abstract][Full Text] [Related]
5. The impact of the implementation of medication for opioid use disorder and COVID-19 in a statewide correctional system on treatment engagement, postrelease continuation of care, and overdose.
Klemperer EM; Wreschnig L; Crocker A; King-Mohr J; Ramniceanu A; Brooklyn JR; Peck KR; Rawson RA; Evans EA
J Subst Use Addict Treat; 2023 Sep; 152():209103. PubMed ID: 37311520
[TBL] [Abstract][Full Text] [Related]
6. Association between treatment setting and outcomes among oregon medicaid patients with opioid use disorder: a retrospective cohort study.
Hartung DM; Markwardt S; Johnston K; Geddes J; Baker R; Leichtling G; Hildebran C; Chan B; Cook RR; McCarty D; Ghitza U; Korthuis PT
Addict Sci Clin Pract; 2022 Aug; 17(1):45. PubMed ID: 35986384
[TBL] [Abstract][Full Text] [Related]
7. Duration of medication treatment for opioid-use disorder and risk of overdose among Medicaid enrollees in 11 states: a retrospective cohort study.
Burns M; Tang L; Chang CH; Kim JY; Ahrens K; Allen L; Cunningham P; Gordon AJ; Jarlenski MP; Lanier P; Mauk R; McDuffie MJ; Mohamoud S; Talbert J; Zivin K; Donohue J
Addiction; 2022 Dec; 117(12):3079-3088. PubMed ID: 35652681
[TBL] [Abstract][Full Text] [Related]
8. High deductible health plans and spending among families with a substance use disorder.
Meiselbach MK; Kennedy-Hendricks A; Schilling C; Busch AB; Huskamp HA; Stuart EA; Hollander MAG; Barry CL; Eisenberg MD
Drug Alcohol Depend; 2022 Dec; 241():109681. PubMed ID: 36370532
[TBL] [Abstract][Full Text] [Related]
9. Follow-up after ED visits for opioid use disorder: Do they reduce future overdoses?
Medicaid Outcomes Distributed Research Network
J Subst Abuse Treat; 2022 Nov; 142():108807. PubMed ID: 35649885
[TBL] [Abstract][Full Text] [Related]
10. Predicting Mortality Risk After a Hospital or Emergency Department Visit for Nonfatal Opioid Overdose.
Guo J; Lo-Ciganic WH; Yang Q; Huang JL; Weiss JC; Cochran G; Malone DC; Kuza CC; Gordon AJ; Donohue JM; Gellad WF
J Gen Intern Med; 2021 Apr; 36(4):908-915. PubMed ID: 33481168
[TBL] [Abstract][Full Text] [Related]
11. Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts.
Chatterjee A; Weitz M; Savinkina A; Macmadu A; Madushani RWMA; Potee RA; Ryan D; Murphy SM; Walley AY; Linas BP
JAMA Netw Open; 2023 Apr; 6(4):e237036. PubMed ID: 37058306
[TBL] [Abstract][Full Text] [Related]
12. Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.
Malta M; Varatharajan T; Russell C; Pang M; Bonato S; Fischer B
PLoS Med; 2019 Dec; 16(12):e1003002. PubMed ID: 31891578
[TBL] [Abstract][Full Text] [Related]
13. Controller Medication Use and Exacerbations for Children and Adults With Asthma in High-Deductible Health Plans.
Galbraith AA; Ross-Degnan D; Zhang F; Wu AC; Sinaiko A; Peltz A; Xu X; Wallace J; Wharam JF
JAMA Pediatr; 2021 Aug; 175(8):807-816. PubMed ID: 33970186
[TBL] [Abstract][Full Text] [Related]
14. Emergency Department Peer Support Program and Patient Outcomes After Opioid Overdose.
Treitler P; Crystal S; Cantor J; Chakravarty S; Kline A; Morton C; Powell KG; Borys S; Cooperman NA
JAMA Netw Open; 2024 Mar; 7(3):e243614. PubMed ID: 38526490
[TBL] [Abstract][Full Text] [Related]
15. Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality.
Johnson K; Hills H; Ma J; Brown CH; McGovern M
Am J Drug Alcohol Abuse; 2021 Mar; 47(2):220-228. PubMed ID: 33054435
[No Abstract] [Full Text] [Related]
16. Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment.
Busch AB; Greenfield SF; Reif S; Normand ST; Huskamp HA
J Subst Abuse Treat; 2020 Aug; 115():108040. PubMed ID: 32600627
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients.
Kilaru AS; Xiong A; Lowenstein M; Meisel ZF; Perrone J; Khatri U; Mitra N; Delgado MK
JAMA Netw Open; 2020 May; 3(5):e205852. PubMed ID: 32459355
[TBL] [Abstract][Full Text] [Related]
18. Postpartum Opioid-Related Mortality in Patients With Public Insurance.
Suarez EA; Huybrechts KF; Straub L; Hernández-Díaz S; Creanga AA; Connery HS; Gray KJ; Vine SM; Jones HE; Bateman BT
Obstet Gynecol; 2023 Apr; 141(4):657-665. PubMed ID: 36897177
[TBL] [Abstract][Full Text] [Related]
19. Cannabis Use and Nonfatal Opioid Overdose among Patients Enrolled in Methadone Maintenance Treatment.
Bryson WC; Morasco BJ; Cotton BP; Thielke SM
Subst Use Misuse; 2021; 56(5):697-703. PubMed ID: 33749499
[TBL] [Abstract][Full Text] [Related]
20. Telemedicine Buprenorphine Initiation and Retention in Opioid Use Disorder Treatment for Medicaid Enrollees.
Hammerslag LR; Mack A; Chandler RK; Fanucchi LC; Feaster DJ; LaRochelle MR; Lofwall MR; Nau M; Villani J; Walsh SL; Westgate PM; Slavova S; Talbert JC
JAMA Netw Open; 2023 Oct; 6(10):e2336914. PubMed ID: 37851446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
